日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Selective depletion of virus-specific CD8 T cells from the liver after PD-1 therapy with Fc-intact antibody during chronic infection

在慢性感染期间,使用Fc完整抗体进行PD-1治疗后,选择性地清除肝脏中的病毒特异性CD8 T细胞

Hashimoto, Masao; Nasti, Tahseen H; Jin, Hyun-Tak; Bu, Melissa; Araki, Koichi; Lee, Junghwa; Valanparambil, Rajesh M; Akhtar, Akil; Khan, Mohammad Affan; Peng, Zhipeng; Hu, Yinghong; McManus, Daniel T; Bahhar, Ilham; Wieland, Andreas; Davis, Carl W; Ramalingam, Suresh S; Sharpe, Arlene H; Ravetch, Jeffrey V; Freeman, Gordon J; Ahmed, Rafi

Antibody-lectin chimeras for glyco-immune checkpoint blockade

用于糖免疫检查点阻断的抗体-凝集素嵌合体

Stark, Jessica C; Gray, Melissa A; Ibarlucea-Benitez, Itziar; Lustig, Marta; Bond, Annalise; Cho, Brian; Govil, Ishika; Luu, Tran; Priestley, Megan J; Veth, Tim S; Errington, Wesley J; Bruncsics, Bence; Ribi, Mikaela K; Williams, Leo A; Sarkar, Casim A; Wisnovsky, Simon; Riley, Nicholas M; Morrissey, Meghan A; Valerius, Thomas; Ravetch, Jeffrey V; Bertozzi, Carolyn R

Asymmetrically glycosylated IgG1 antibodies are universal and drive human disease.

不对称糖基化的 IgG1 抗体是普遍存在的,并且是人类疾病的驱动因素。

Azzam Tala, Bournazos Stylianos, Gunduz Hasret, Adams Trevor, Flowers Maria W, Niejadlik Emily G, Duong Veasna, Brown Trenton J, Roberts Anne M, Sastre Diego E, Avci Fikri Y, Lam Wilbur A, Cantaert Tineke, Roberts Blaine R, Diamond Betty, Ravetch Jeffrey V, Du Jonathan J, Sundberg Eric J

FcγRIIIa is a noncanonical costimulatory molecule for CD8 T cells

FcγRIIIa是CD8 T细胞的非经典共刺激分子。

Kao, Kevin S; Pihlstrom, Nicole L; Niejadlik, Emily G; Cantaert, Tineke; Ahmed, Rafi; Ravetch, Jeffrey V; Bournazos, Stylianos

A novel mouse strain optimized for chronic human antibody administration

一种新型小鼠品系,针对慢性人抗体给药进行了优化

Gupta, Aaron; Smith, Patrick; Bournazos, Stylianos; Ravetch, Jeffrey V

Antibody fucosylation predicts disease severity in secondary dengue infection

抗体岩藻糖基化可预测继发性登革热感染的疾病严重程度

Bournazos, Stylianos; Vo, Hoa Thi My; Duong, Veasna; Auerswald, Heidi; Ly, Sowath; Sakuntabhai, Anavaj; Dussart, Philippe; Cantaert, Tineke; Ravetch, Jeffrey V

Dendritic cell targeting with Fc-enhanced CD40 antibody agonists induces durable antitumor immunity in humanized mouse models of bladder cancer

利用Fc增强型CD40抗体激动剂靶向树突状细胞,可在人源化小鼠膀胱癌模型中诱导持久的抗肿瘤免疫。

Garris, Christopher S; Wong, Jeffrey L; Ravetch, Jeffrey V; Knorr, David A

Four keys to unlock IgG

解锁IgG的四个关键

Nimmerjahn, Falk; Ravetch, Jeffrey V

One-Pot Conversion of Free Sialoglycans to Functionalized Glycan Oxazolines and Efficient Synthesis of Homogeneous Antibody-Drug Conjugates through Site-Specific Chemoenzymatic Glycan Remodeling

通过位点特异性化学酶法糖基化重塑,一锅法将游离唾液酸聚糖转化为功能化糖基恶唑啉,并高效合成均一抗体-药物偶联物

Ou, Chong; Li, Chao; Zhang, Roushu; Yang, Qiang; Zong, Guanghui; Dai, Yuanwei; Francis, Rebecca L; Bournazos, Stylianos; Ravetch, Jeffrey V; Wang, Lai-Xi

The role of IgG Fc receptors in antibody-dependent enhancement

IgG Fc受体在抗体依赖性增强中的作用

Bournazos, Stylianos; Gupta, Aaron; Ravetch, Jeffrey V